Lisa N. Colleran

Lisa N. Colleran (board member) discloses dealings in 5 companies, chiefly Lifecell Corp, Establishment Labs Holdings Inc. and TELA Bio, Inc. Over a trading history stretching from 3 January 2006 to 28 May 2025, the count stands at 66 filings.

Market trades split into 25 purchases (€75k) and 5 sales (€1.1M). Taken together, the sales exceed the purchases by €1.0M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 19 share grants and 12 option exercises.

The median purchase comes to €94. On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 30 May 2025, the filings show a share grant in TELA Bio, Inc. The last insider purchase was made public on 27 May 2020, 2,341 days ago. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.